Preservation of Pancreatic β-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance
in High-Risk Hispanic Women
(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.
Cumulative incidence rates of type 2 diabetes in women who returned for at least one follow-up visit after randomization to
placebo or troglitazone. The rate in the troglitazone group was significantly lower than the rate in the placebo group (P = 0.009).